Pharmaceutical Market Access and Drug Safety Act of 2007

To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.

1/10/2007--Introduced.
Pharmaceutical Market Access and Drug Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by:
(1) a registered importer; or
(2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences. Prohibits manufacturers from:
(1) discriminating against registered exporters or importers;
(2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country;
(3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or
(4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug. States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement. Requires the Secretary to educate consumers regarding prescription drug importation. Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA. Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.


... morehide bill summary

Sponsor

• Rep. Rahm Emanuel [D, IL-5]
• and 109 Co-Sponsors
  • Rep. Neil Abercrombie [D, HI-1]
  • Rep. Gary Ackerman [D, NY-5]
  • Thomas Allen
  • Rep. Jason Altmire [D, PA-4]
  • Rep. John Barrow [D, GA-12]
  • Rep. Roscoe Bartlett [R, MD-6]
  • Rep. Melissa Bean [D, IL-8]
  • Rep. Shelley Berkley [D, NV-1]
  • Rep. Howard Berman [D, CA-28]
  • Rep. Robert Berry [D, AR-1]
  • Rep. Timothy Bishop [D, NY-1]
  • Rep. Earl Blumenauer [D, OR-3]
  • Rep. Frederick Boucher [D, VA-9]
  • Rep. Virginia Brown-Waite [R, FL-5]
  • Rep. Dan Burton [R, IN-5]
  • Rep. Russ Carnahan [D, MO-3]
  • Rep. Christopher Carney [D, PA-10]
  • Julia Carson
  • Rep. Kathy Castor [D, FL-11]
  • Rep. Ben Chandler [D, KY-6]
  • Rep. Emanuel Cleaver [D, MO-5]
  • Rep. Steve Cohen [D, TN-9]
  • Rep. Jim Cooper [D, TN-5]
  • Rep. Jim Costa [D, CA-20]
  • Rep. Jerry Costello [D, IL-12]
  • Rep. Elijah Cummings [D, MD-7]
  • Rep. Peter DeFazio [D, OR-4]
  • Rep. William Delahunt [D, MA-10]
  • Rep. Rosa DeLauro [D, CT-3]
  • Rep. Keith Ellison [D, MN-5]
  • Rep. Jo Ann Emerson [R, MO-8]
  • Rep. Barney Frank [D, MA-4]
  • Rep. Gabrielle Giffords [D, AZ-8]
  • Rep. Barton Gordon [D, TN-6]
  • Rep. Al Green [D, TX-9]
  • Rep. Raymond Green [D, TX-29]
  • Rep. Luis Gutiérrez [D, IL-4]
  • Rep. John Hall [D, NY-19]
  • Rep. Phil Hare [D, IL-17]
  • Rep. Jane Harman [D, CA-36]
  • Rep. Doc Hastings [R, WA-4]
  • Rep. Alcee Hastings [D, FL-23]
  • Rep. Maurice Hinchey [D, NY-22]
  • Rep. Rubén Hinojosa [D, TX-15]
  • Rep. Mazie Hirono [D, HI-2]
  • Rep. Peter Hoekstra [R, MI-2]
  • Rep. Tim Holden [D, PA-17]
  • Darlene Hooley
  • Rep. Steve Israel [D, NY-2]
  • Rep. Henry Johnson [D, GA-4]
  • Rep. Walter Jones [R, NC-3]
  • Rep. Steve Kagen [D, WI-8]
  • Rep. Paul Kanjorski [D, PA-11]
  • Rep. Marcy Kaptur [D, OH-9]
  • Rep. Dale Kildee [D, MI-5]
  • Tom Lantos
  • Rep. Rick Larsen [D, WA-2]
  • Rep. Steven LaTourette [R, OH-14]
  • Rep. John Lewis [D, GA-5]
  • Rep. Daniel Lipinski [D, IL-3]
  • Rep. Nita Lowey [D, NY-18]
  • Rep. James Marshall [D, GA-8]
  • Rep. Carolyn McCarthy [D, NY-4]
  • Rep. Betty McCollum [D, MN-4]
  • Rep. James McGovern [D, MA-3]
  • Rep. Jerry McNerney [D, CA-11]
  • Michael McNulty
  • Martin Meehan
  • Rep. George Miller [D, CA-7]
  • Rep. Dennis Moore [D, KS-3]
  • Rep. James Moran [D, VA-8]
  • Rep. Christopher Murphy [D, CT-5]
  • Rep. Patrick Murphy [D, PA-8]
  • Rep. John Murtha [D, PA-12]
  • Marilyn Musgrave
  • Rep. Jerrold Nadler [D, NY-8]
  • Rep. James Oberstar [D, MN-8]
  • Rep. John Olver [D, MA-1]
  • Rep. Edward Pastor [D, AZ-4]
  • Rep. Donald Payne [D, NJ-10]
  • Rep. Collin Peterson [D, MN-7]
  • Rep. Thomas Petri [R, WI-6]
  • Rep. Todd Platts [R, PA-19]
  • James Ramstad
  • Rep. Silvestre Reyes [D, TX-16]
  • Rep. C.A. Ruppersberger [D, MD-2]
  • Rep. Linda Sánchez [D, CA-39]
  • Rep. Janice Schakowsky [D, IL-9]
  • Christopher Shays
  • Rep. Carol Shea-Porter [D, NH-1]
  • Rep. Michael Simpson [R, ID-2]
  • Rep. Louise Slaughter [D, NY-28]
  • Rep. Victor Snyder [D, AR-2]
  • Rep. Hilda Solis [D, CA-32]
  • Rep. Fortney Stark [D, CA-13]
  • Rep. Betty Sutton [D, OH-13]
  • Rep. Gene Taylor [D, MS-4]
  • Rep. John Tierney [D, MA-6]
  • Rep. Christopher Van Hollen [D, MD-8]
  • Rep. Zach Wamp [R, TN-3]
  • Rep. Debbie Wasserman Schultz [D, FL-20]
  • Rep. Anthony Weiner [D, NY-9]
  • Rep. Peter Welch [D, VT-0]
  • Rep. Robert Wexler [D, FL-19]
  • Rep. Charles Wilson [D, OH-6]
  • Rep. Frank Wolf [R, VA-10]
  • Rep. Lynn Woolsey [D, CA-6]
  • Rep. David Wu [D, OR-1]
  • Albert Wynn
  close

Committees

• House Energy and Commerce
• 2 more
  • House Energy and Commerce
  • House Energy and Commerce
  close

Amendments

This bill has no amendments.

Amendments to H.R.380

Number	Status	Purpose

Bill Status

Make a Bill Status Widget

	OpenCongress widgets allow you to display information about bills and issue areas on your own website or blog. First, select which bill or issue you want to track, then customize the appearance of the panel, and finally paste a simple chunk of HTML into your site. Now your community will have an easy, up-to-date way to track the status of important bills and issues in Congress.

Introduced		Voted on by House		Voted on by Senate		Considered By President		Bill Becomes Law
January 10, 2007

Show All Actions (4 actions)Hide Actions

All Bill Actions

• Feb 02, 2007: Referred to the Subcommittee on Health.
• Feb 02, 2007: Referred to the Subcommittee on Commerce, Trade and Consumer Protection.
• Introduced on Jan 10, 2007.
• Jan 10, 2007: Referred to the House Committee on Energy and Commerce.

---

Related Bills:

• S.242

Related Issue Areas:

• Medicine
• Accreditation (Medical care)
• Actions and defenses
• Administrative fees
• 95 more
• Administrative procedure
• Administrative remedies
• Australia
• Budgets
• Business
• Business records
• Canada
• Checks
• Civil liberties
• Congress
• Congressional reporting requirements
• Consumer education
• Consumers
• Contracts
• Credit cards
• Criminal justice
• Customs administration
• Damages
• Defective products
• Department of Health and Human Services
• Directories
• Drug advertising
• Drug approvals
• Drug industry
• Drugs
• East Asia
• Education
• Electronic commerce
• Electronic data interchange
• Electronic funds transfers
• Electronic government information
• Europe
• European Union
• Evidence (Law)
• Executive departments
• Export controls
• Exports
• Federal Trade Commission
• Federal preemption
• Federal-state relations
• Finance
• Fines (Penalties)
• Food and Drug Administration (FDA)
• Forfeiture
• Fraud
• Government information
• Government paperwork
• Government publicity
• Governmental investigations
• Higher education
• Identification devices
• Import restrictions
• Imports
• Independent regulatory commissions
• Injunctions
• Intellectual property
• Interactive media
• Internet
• Japan
• Labeling
• Law
• Liability (Law)
• Licenses
• Medical associations
• Medical care
• Medical education
• Medical records
• Medical tests
• New Zealand
• Oceania
• Packaging
• Parties to actions
• Patent infringement
• Patents
• Pharmaceutical research
• Pharmacies
• Pharmacists
• Physical examinations
• Prescription pricing
• Price discrimination
• Product counterfeiting
• Restrictive trade practices
• Right of privacy
• Science policy
• State and local government
• State laws
• Surety and fidelity
• Switzerland
• Technology
• Telecommunication
• Telephone
• Trade
• User charges
• Web sites
• Wholesale trade

Data from the Congressional Research Service

Show More User Statistics... Hide User Statistics

In the News

September 13, 2007 NFIB Shouldn't Support Drug Reimportation Bill

... Federation of Independent Business -- which recently announced support for the Pharmaceutical Market Access and Drug Safety Act (S 242 and HR 380), ...

Was this article useful? Yes or No

Source: eMaxHealth.com, NC

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

March 07, 2007 AARP Presses Case for Rx Importation

In January, AARP endorsed the bipartisan "Pharmaceutical Market Access and Drug Safety Act of 2007" (S. 242, HR 380), which would legalize the importation ...

Was this article useful? Yes or No

Source: PR Newswire (press release), NY

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

March 07, 2007 AARP Presses Case for Rx Importation

In January, AARP endorsed the bipartisan "Pharmaceutical Market Access and Drug Safety Act of 2007" (S. 242, HR 380), which would legalize the importation ...

Was this article useful? Yes or No

Source: PharmaLive.com (press release), PA

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

See most useful news articles

Information made available by:

Blog Coverage

December 31, 2008 Eye on FDA: Welcome 2009 - What's in Store for the Pharmaceutical ...

H.R. 380 - Pharmaceutical Market Access and Drug Safety Act of 2007 · H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 · H.R. 63 - RU-486 Suspension and Review Act of 2007 · H.R. 780 - Counterfeit Drug Prevention Act o

Was this article useful? Yes or No

Source: Eye on FDA

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

December 29, 2008 Eye on FDA: New Prostate Cancer Treatment Approved by FDA

H.R. 380 - Pharmaceutical Market Access and Drug Safety Act of 2007 · H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 · H.R. 63 - RU-486 Suspension and Review Act of 2007 · H.R. 780 - Counterfeit Drug Prevention Act o

Was this article useful? Yes or No

Source: Eye on FDA

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

December 21, 2008 Eye on FDA: Weekly Roundup - 12/19/08

H.R. 380 - Pharmaceutical Market Access and Drug Safety Act of 2007 · H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 · H.R. 63 - RU-486 Suspension and Review Act of 2007 · H.R. 780 - Counterfeit Drug Prevention Act o

Was this article useful? Yes or No

Source: Eye on FDA

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

76 more posts...
See most useful blog posts

Information made available by: